Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$217M |
| 2 |
JPMorgan Chase
JPM
|
+$213M |
| 3 |
Intel
INTC
|
+$200M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$184M |
| 5 |
TECD
Tech Data Corp
TECD
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$685M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$127M |
| 3 |
Meta Platforms (Facebook)
META
|
+$122M |
| 4 |
Merck
MRK
|
+$110M |
| 5 |
NVIDIA
NVDA
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 8.62% |
| 2 | Technology | 7.54% |
| 3 | Financials | 6.93% |
| 4 | Consumer Discretionary | 6.74% |
| 5 | Industrials | 6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
PJT Partners
PJT
$4.41B
| $13.1M | 0.02% |
256,122
+196,111
| +327% | +$9.67M |
|
1002
PUT
American Airlines Group
AAL
$10.9B
| $13.1M | 0.02% |
1,005,800
+741,800
| +281% | +$9M |
|
1003
Castle Biosciences
CSTL
$950M
| $13.1M | 0.02% |
347,928
+138,479
| +66% | +$4.73M |
|
1004
Evercore
EVR
$12.5B
| $13.1M | 0.02% |
221,932
+124,804
| +128% | +$6.79M |
|
1005
Associated Banc-Corp
ASB
$6.01B
| $13.1M | 0.02% |
954,455
+371,062
| +64% | +$5.04M |
|
1006
Rush Street Interactive
RSI
$2.93B
| $13M | 0.02% |
+1,299,680
| New | +$12.7M |
|
|
WPX
1007
DELISTED
WPX Energy, Inc.
WPX
| $13M | 0.02% |
2,043,212
+2,005,531
| +5,322% | +$11.3M |
|
1008
CALL
Analog Devices
ADI
$184B
| $13M | 0.02% |
106,100
+97,700
| +1,163% | +$10.7M |
|
|
RDFN
1009
DELISTED
Redfin
RDFN
| $13M | 0.02% |
310,412
+211,668
| +214% | +$5.58M |
|
1010
ARKO Corp
ARKO
$845M
| $13M | 0.02% |
1,255,999
-294,300
| -19% | -$2.95M |
|
1011
Usana Health Sciences
USNA
$422M
| $13M | 0.02% |
176,716
+155,567
| +736% | +$12.2M |
|
1012
PUT
3M
MMM
$92.2B
| $13M | 0.02% |
99,388
+97,116
| +4,274% | +$12.2M |
|
1013
MGIC Investment
MTG
$6.34B
| $13M | 0.02% |
1,582,796
+1,476,545
| +1,390% | +$11M |
|
1014
Axsome Therapeutics
AXSM
$10.9B
| $12.9M | 0.02% |
157,254
+4,923
| +3% | +$379K |
|
1015
Ally Financial
ALLY
$13.7B
| $12.9M | 0.02% |
652,341
+631,217
| +2,988% | +$10.7M |
|
1016
CVS Health
CVS
$133B
| $12.9M | 0.02% |
199,023
-704,518
| -78% | -$44.4M |
|
1017
AptarGroup
ATR
$8.72B
| $12.9M | 0.02% |
115,287
-1,396
| -1% | -$149K |
|
|
GLUU
1018
DELISTED
Glu Mobile Inc.
GLUU
| $12.9M | 0.02% |
+1,391,111
| New | +$11.8M |
|
|
FOLD
1019
DELISTED
Amicus Therapeutics
FOLD
| $12.9M | 0.02% |
853,323
-404,851
| -32% | -$4.93M |
|
1020
Brown-Forman Class B
BF.B
$12.9B
| $12.8M | 0.02% |
201,754
+193,861
| +2,456% | +$12.4M |
|
1021
Microvast
MVST
$293M
| $12.8M | 0.02% |
1,254,290
| – | – |
|
1022
Kulicke & Soffa
KLIC
$4.87B
| $12.8M | 0.02% |
+613,924
| New | +$13.9M |
|
1023
Syndax Pharmaceuticals
SNDX
$1.73B
| $12.8M | 0.02% |
862,048
+580,957
| +207% | +$8.85M |
|
|
CCXI
1024
DELISTED
ChemoCentryx, Inc.
CCXI
| $12.8M | 0.02% |
221,832
-133,399
| -38% | -$7.26M |
|
1025
Progress Software
PRGS
$1.71B
| $12.7M | 0.02% |
328,286
+47,652
| +17% | +$1.82M |
|
Similar funds
Millennium Management's Q2 2020 Portfolio in Review
As of Q2 2020, Millennium Management held 4,914 positions worth $73B, up 64% from $44.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Millennium Management deployed $17.6B of net new capital in Q2 2020, opening 1,140 new positions and adding to 1,565 existing holdings. Its largest new stake was Global Payments: 1,008,446 shares worth $171M.
By sector, the portfolio is most concentrated in Healthcare at 8.6% of assets, down from 11% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $127M trimmed.
- Millennium Management's largest Q2 2020 buy was Global Payments: 1,008,446 shares worth $171M.
- Millennium Management added most to Lowe's Companies in Q2 2020, an estimated $217M increase.
- Millennium Management's biggest Q2 2020 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $127M.
- Millennium Management fully exited Allergan plc in Q2 2020, selling an estimated $685M.
- Millennium Management's ten largest holdings make up 20% of its $73B portfolio in Q2 2020.
- Millennium Management opened 1,140 new positions and closed 798 in Q2 2020.
- Millennium Management's portfolio value rose 64% quarter-over-quarter to $73B.
Based on Millennium Management's 13F filing for Q2 2020, filed 14 Aug 2020.